How can we hold hospitals accountable for their community benefit spending? At a recent webinar hosted by Community Catalyst, Lown leaders discussed measuring hospital community investment and opportunities for advocacy. More
Hospitals are facing persistent staffing issues and many are in poor financial shape....but their CEOs keep getting bonuses. Could pay equity be the solution that stabilizes our hospitals? More
An investigation of one Alzheimer's Disease drug and the approval of another offer lessons on accountability and evidence for new drug approvals. More
Last week, we hosted the 6th annual Shkreli Awards, calling out the worst profiteers and dysfunction in the healthcare system in 2022. In a perfect world, these awards wouldn’t be necessary. In our world, we have a plethora of candidates to consider. More
A new series of articles on healthcare segregation provides a call to action and a way forward for all actors in the healthcare system looking to improve racial and economic equity More
Can community empowerment solve persistent population health disparities that other strategies have failed to fix? More
It's the time of year where most of us are getting into the "giving spirit." But recent investigations show that some hospitals are instead putting up obstacles to financial assistance. More
Pediatric units are closing across the country, leaving parents and their sick kids without easy access to healthcare. Why is this happening, and what are the long-term consequences? More
With $8 and 9 words, one internet troll is forcing insulin manufacturers to answer the question of why the drug is so unaffordable More
Which hospitals are walking the talk on social responsibility? A new feature in Frontiers of Health Services Management showcases the Lown Index and winning hospitals. More
A new report examining the finances of nonprofit hospitals in New York City finds that some hospitals fall significantly short on expected community investments. More
Nominations for the annual Bernard Lown Award for Social Responsibility are now open! More
What could be a fruitful conversation on racial equity is being co-opted by pharmaceutical companies to sell unproven drugs. More
Skipping doses, intentionally undermedicating, not eating - these are all measures 1.3 million Americans are forced to take to keep their insulin costs down. More
From approval to withdrawal, the story of Makena shows some of the major pitfalls of the FDA's drug approval process. More
The Lown Institute's annual Shkreli Awards highlight the most egregious examples of profiteering and dysfunction in our healthcare system. From systemic failures to negligence to fraud, the Shkreli Awards are here to spotlight the worst. On January 10 at 1 pm ET, we will be counting down the top ten most glaring examples of our broken system, and you're invited! More
The reasoning behind this decision has to do with a complex bioethical question - if there is the potential to treat a previously untreatable disease with a new pharmaceutical, but the consequences are unknown, do you prescribe the drug? Is the unknown enough to deny patients hope? More
Last week, Lown experts Dr. Vikas Saini and Judith Garber were featured in a conversation about the responsibility between hospitals and the community at the 2022 Medicaid Institute, hosted by the Center for Community Solutions. More
How can mortality be reduced by colonoscopies but not by a colonoscopy screening program? We break down the results from the groundbreaking NordICC trial. More
Over the past 20 years, private equity investments in the United States healthcare sector have increased twentyfold, reaching above $100 billion. How have these acquisitions changed the business practices of hospitals and other healthcare organizations? This blog is the second in a series the Lown Institute is developing on the effects and implications of private equity acquisitions sweeping the healthcare industry. More